Received Aug 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
A patient received 1st dose of Twinrix in February and did not came back to the second dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult male patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (first dose of Twinrix in February 2025). The patient did not receive the 2nd dose of Twinrix. The patient experienced incomplete course of vaccination (Verbatim: A patient received 1st dose of Twinrix in February and did not came back to the second dose.). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-AUG-2025 Pharmacist called to report that an adult male patient got the first dose of Twinrix in February 2025 but he did not receive the second dose one month later. Till the time of reporting, the patient did not receive 2nd dose of Twinrix, which led to incomplete course of vaccination.